ELISA is performed on a population with low prevalence. What would be the result of performing double screening ELISA tests?
**Core Concept**
The ELISA (Enzyme-Linked Immunosorbent Assay) test is a laboratory technique for detecting and quantifying specific antibodies or antigens in a sample. When performed on a population with low prevalence, the test's sensitivity and specificity become crucial in minimizing false positives and false negatives.
**Why the Correct Answer is Right**
Performing double screening ELISA tests on a population with low prevalence involves repeating the test on the same sample to confirm the result. This approach is essential in reducing the likelihood of false positives, which can be particularly problematic in low-prevalence populations. The repeated testing helps to increase the test's specificity by minimizing the impact of false positives, thereby improving the overall accuracy of the results.
**Why Each Wrong Option is Incorrect**
**Option A:** Performing double screening ELISA tests would not significantly reduce the number of false negatives, as false negatives are primarily a result of test insensitivity rather than false positives.
**Option B:** Double screening ELISA tests would not improve the test's sensitivity, as sensitivity is the test's ability to correctly identify those with the disease, which is not directly affected by repeating the test.
**Option C:** Double screening ELISA tests would not be a cost-effective approach, as it would increase the time and resources required for testing without providing significant benefits in terms of accuracy.
**Clinical Pearl / High-Yield Fact**
In low-prevalence populations, the positive predictive value of a test is often low, which means that a positive result may not necessarily indicate the presence of the disease. Therefore, it is essential to confirm results through repeated testing or other diagnostic methods to minimize false positives and ensure accurate diagnosis.
**Correct Answer:** C. This approach is not cost-effective and does not address the primary issue of low prevalence.